- Home
- REXR vs SNN Comparison
REXR vs SNN Comparison
Compare REXR & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REXR
- SNN
- Stock Information
- Founded
- REXR 2013
- SNN 1856
- Country
- REXR United States
- SNN United Kingdom
- Employees
- REXR N/A
- SNN N/A
- Industry
- REXR Real Estate Investment Trusts
- SNN Industrial Specialties
- Sector
- REXR Real Estate
- SNN Health Care
- Exchange
- REXR Nasdaq
- SNN Nasdaq
- Market Cap
- REXR 8.7B
- SNN 13.2B
- IPO Year
- REXR 2013
- SNN 1999
- Fundamental
- Price
- REXR $36.91
- SNN $30.28
- Analyst Decision
- REXR Hold
- SNN Hold
- Analyst Count
- REXR 9
- SNN 3
- Target Price
- REXR $39.67
- SNN $27.50
- AVG Volume (30 Days)
- REXR 2.9M
- SNN 1.2M
- Earning Date
- REXR 07-16-2025
- SNN 07-31-2025
- Dividend Yield
- REXR 4.64%
- SNN 2.37%
- EPS Growth
- REXR 12.67
- SNN 56.15
- EPS
- REXR 1.23
- SNN 0.47
- Revenue
- REXR $974,598,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- REXR $10.10
- SNN $6.87
- Revenue Next Year
- REXR $7.08
- SNN $5.19
- P/E Ratio
- REXR $30.15
- SNN $33.29
- Revenue Growth
- REXR 18.04
- SNN 4.70
- 52 Week Low
- REXR $29.68
- SNN $23.69
- 52 Week High
- REXR $52.61
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- REXR 55.69
- SNN 54.96
- Support Level
- REXR $36.62
- SNN $29.50
- Resistance Level
- REXR $37.79
- SNN $31.43
- Average True Range (ATR)
- REXR 0.88
- SNN 0.42
- MACD
- REXR -0.00
- SNN 0.02
- Stochastic Oscillator
- REXR 69.34
- SNN 56.27
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.